Zhejiang Starry Pharm Co Ltd (603520) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.004x

Based on the latest financial reports, Zhejiang Starry Pharm Co Ltd (603520) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥9.76 Million ≈ $1.43 Million USD) by net assets (CN¥2.61 Billion ≈ $381.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhejiang Starry Pharm Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Zhejiang Starry Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Zhejiang Starry Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Starry Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Starry Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore Zhejiang Starry Pharm Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
TPG RE Finance Trust Inc NYSE:TRTX	0.021x
Beijing Sanlian Hope Shin-Gosen Technical Service Co Ltd SHE:300384	-0.003x
WA1 Resources Ltd AU:WA1	-0.012x
Hangzhou Dadi Haiyang Environmental Protection Co. Ltd. SHE:301068	N/A
Lao Feng Xiang Co Ltd B SHG:900905	0.148x
Guangzhou Jet Bio-Filtration Co Ltd SHG:688026	0.038x
Ashapura Minechem Limited NSE:ASHAPURMIN	0.135x
Ichitan Group Public Company Limited BK:ICHI	-0.015x

Annual Cash Flow Conversion Efficiency for Zhejiang Starry Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Starry Pharm Co Ltd from 2011 to 2025. View 603520 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.56 Billion ≈ $375.23 Million	CN¥3.67 Million ≈ $536.56K	0.001x	-98.05%
2024-12-31	CN¥2.63 Billion ≈ $385.50 Million	CN¥193.50 Million ≈ $28.32 Million	0.073x	+180.09%
2023-12-31	CN¥1.76 Billion ≈ $257.38 Million	CN¥46.13 Million ≈ $6.75 Million	0.026x	+159.27%
2022-12-31	CN¥1.77 Billion ≈ $259.18 Million	CN¥-78.37 Million ≈ $-11.47 Million	-0.044x	-119.26%
2021-12-31	CN¥2.21 Billion ≈ $324.06 Million	CN¥508.84 Million ≈ $74.46 Million	0.230x	+145.57%
2020-12-31	CN¥1.86 Billion ≈ $272.87 Million	CN¥174.48 Million ≈ $25.53 Million	0.094x	-60.99%
2019-12-31	CN¥1.03 Billion ≈ $150.53 Million	CN¥246.77 Million ≈ $36.11 Million	0.240x	+15.41%
2018-12-31	CN¥922.96 Million ≈ $135.06 Million	CN¥191.84 Million ≈ $28.07 Million	0.208x	+901.60%
2017-12-31	CN¥872.44 Million ≈ $127.67 Million	CN¥18.10 Million ≈ $2.65 Million	0.021x	+123.47%
2016-12-31	CN¥827.01 Million ≈ $121.02 Million	CN¥7.68 Million ≈ $1.12 Million	0.009x	-95.52%
2015-12-31	CN¥457.70 Million ≈ $66.98 Million	CN¥94.88 Million ≈ $13.88 Million	0.207x	-37.79%
2014-12-31	CN¥432.13 Million ≈ $63.23 Million	CN¥144.00 Million ≈ $21.07 Million	0.333x	+71.57%
2013-12-31	CN¥386.11 Million ≈ $56.50 Million	CN¥74.99 Million ≈ $10.97 Million	0.194x	-36.70%
2012-12-31	CN¥336.81 Million ≈ $49.29 Million	CN¥103.34 Million ≈ $15.12 Million	0.307x	+325.46%
2011-12-31	CN¥301.81 Million ≈ $44.16 Million	CN¥-41.07 Million ≈ $-6.01 Million	-0.136x	--

About Zhejiang Starry Pharm Co Ltd

SHG:603520 China Drug Manufacturers - Specialty & Generic

Market Cap

$555.57 Million

CN¥3.80 Billion CNY

Market Cap Rank

#11880 Global

#3447 in China

Share Price

CN¥8.66

Change (1 day)

+0.58%

52-Week Range

CN¥8.00 - CN¥13.75

All Time High

CN¥651.92